Tag: Exact Sciences

All

Walgreens Partners to Expand Colorectal Cancer Screening Access

The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.

Abbott to Acquire Exact Sciences in $21 Billion Agreement
Blood Test Shows Superior Sensitivity for Early-Stage Liver Cancer Detection
FDA Approves Exact Sciences’ Non-Invasive Test for Colorectal Cancer Screening
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection Study
Oncoguard Esophagus Test Achieves High Sensitivity, Specificity
Next-Gen Cologuard Test Demonstrates High Sensitivity, Specificity
Long-Term Study Validates Genomic Assay for Prostate Cancer
Phillips-Medisize, Exact Sciences Collaborate to Fight Colorectal Cancer
Oncoguard Liver Liquid Biopsy Test Shows Potential For Better Early-stage Cancer Detection

All

Oncotype DX Test Can Spare Chemotherapy for Women with Certain Breast Cancers

Data from RxPONDER trial successfully defined the benefit of chemotherapy in early-stage, node-positive breast cancer patients with Oncotype DX Breast Recurrence Score results of 0 to 25.